Lv4
530 积分 2023-01-29 加入
ADME and DMPK considerations for the discovery and development of antibody drug conjugates (ADCs)
1个月前
已完结
Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall response
1个月前
已完结
Integrated Two-Analyte Population Pharmacokinetics Model of Patritumab Deruxtecan (HER3-DXd) Monotherapy in Patients with Solid Tumors
1个月前
已完结
Isoalantolactone induces AML pyroptosis and potentiates α-PD-1 efficacy by targeting selenoprotein TXNRD1
1个月前
已完结
Pediatric Versus Adult Chronic Rhinosinusitis
1个月前
已完结
2022—2023年中国11个城市3~18岁儿童青少年喘息的现况调查及相关因素分析
2个月前
已完结
Population Pharmacokinetics of Dupilumab in Adults, Adolescents, and Children With Eosinophilic Esophagitis
2个月前
已完结
Population Pharmacokinetics and Exposure‐Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light‐Chain Amyloidosis
3个月前
已完结
Pharmacokinetic and Pharmacodynamic Modeling of Tezepelumab to Guide Phase 3 Dose Selection for Patients With Severe Asthma
4个月前
已完结
Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody
4个月前
已完结
皖公网安备34019202002308
